Ventricle Health, a virtual cardiac care provider, has secured $8m in seed financing to expand its heart failure management therapeutic model in association with value-based care groups and payers.

This round was led by RA Capital Management, which was joined by other investors including Waterline Ventures.

The company’s care model focuses on established guideline-directed medical therapy (GDMT) pathways, offering patients the convenience of cardiology care appointments from their homes in three days.

Ventricle Health's home-based and virtually enabled care model aims to reduce the average annual cost of heart failure care by 30-50%.

Its leadership team is said to include heart failure clinicians, value-based care operators, and digital health innovators.

The start-up is currently operational, providing virtual and home-based clinical services to support accountable care organisations (ACOs), primary care practices, and payer partners in the Mid-Atlantic, Texas, Ohio, and Florida, with plans to expand into more markets.

Ventricle Health founder Dr. Daniel Bensimhon said: “Our foundational service lines offer a rapid path for either payers or value-based provider groups to connect heart failure patients to high quality cardiology services and provides a model for cardiologists to effectively manage more patients.

“Study after study has shown that getting heart failure patients on appropriate guideline-directed medical therapy can dramatically improve health outcomes and lead to marked reductions in costs and improvements in quality of life in just weeks – yet typically less than 20% of our patients are on these medications even when they come out of the hospital. Ventricle is here to change that.”